Labcorp Holdings Gross Margin 2010-2025 | LH
Current and historical gross margin for Labcorp Holdings (LH) over the last 10 years. The current gross profit margin for Labcorp Holdings as of June 30, 2025 is %.
| Labcorp Holdings Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-06-30 | $13.48B | $3.79B | 28.14% |
| 2025-03-31 | $13.18B | $3.67B | 27.88% |
| 2024-12-31 | $13.01B | $3.62B | 27.85% |
| 2024-09-30 | $12.71B | $3.55B | 27.91% |
| 2024-06-30 | $12.49B | $3.50B | 27.99% |
| 2024-03-31 | $12.30B | $3.41B | 27.73% |
| 2023-12-31 | $12.16B | $3.36B | 27.66% |
| 2023-09-30 | $11.30B | $3.19B | 28.22% |
| 2023-06-30 | $11.11B | $3.23B | 29.02% |
| 2023-03-31 | $11.00B | $3.33B | 30.23% |
| 2022-12-31 | $11.87B | $3.71B | 31.26% |
| 2022-09-30 | $10.76B | $3.81B | 35.36% |
| 2022-06-30 | $11.96B | $4.31B | 36.00% |
| 2022-03-31 | $12.88B | $4.63B | 35.94% |
| 2021-12-31 | $13.14B | $4.99B | 38.01% |
| 2021-09-30 | $16.56B | $6.16B | 37.18% |
| 2021-06-30 | $16.39B | $6.33B | 38.61% |
| 2021-03-31 | $15.32B | $5.82B | 38.02% |
| 2020-12-31 | $13.98B | $4.95B | 35.43% |
| 2020-09-30 | $12.44B | $3.87B | 31.10% |
| 2020-06-30 | $11.48B | $3.13B | 27.25% |
| 2020-03-31 | $11.59B | $3.19B | 27.54% |
| 2019-12-31 | $11.56B | $3.25B | 28.15% |
| 2019-09-30 | $11.39B | $3.20B | 28.13% |
| 2019-06-30 | $11.29B | $3.18B | 28.13% |
| 2019-03-31 | $11.28B | $3.19B | 28.26% |
| 2018-12-31 | $11.33B | $3.18B | 28.02% |
| 2018-09-30 | $11.29B | $3.22B | 28.53% |
| 2018-06-30 | $11.08B | $3.22B | 29.02% |
| 2018-03-31 | $10.74B | $3.16B | 29.40% |
| 2017-12-31 | $10.31B | $3.09B | 30.00% |
| 2017-09-30 | $9.90B | $2.74B | 27.64% |
| 2017-06-30 | $9.70B | $2.74B | 28.27% |
| 2017-03-31 | $9.60B | $2.79B | 29.06% |
| 2016-12-31 | $9.55B | $2.85B | 29.87% |
| 2016-09-30 | $9.52B | $3.13B | 32.93% |
| 2016-06-30 | $9.42B | $3.11B | 33.03% |
| 2016-03-31 | $9.26B | $3.06B | 33.02% |
| 2015-12-31 | $8.68B | $2.90B | 33.46% |
| 2015-09-30 | $7.89B | $2.71B | 34.34% |
| 2015-06-30 | $7.13B | $2.52B | 35.30% |
| 2015-03-31 | $6.37B | $2.31B | 36.27% |
| 2014-12-31 | $6.01B | $2.20B | 36.66% |
| 2014-09-30 | $5.94B | $2.18B | 36.78% |
| 2014-06-30 | $5.85B | $2.16B | 36.95% |
| 2014-03-31 | $5.80B | $2.17B | 37.39% |
| 2013-12-31 | $5.81B | $2.22B | 38.27% |
| 2013-09-30 | $5.78B | $2.24B | 38.69% |
| 2013-06-30 | $5.73B | $2.24B | 39.12% |
| 2013-03-31 | $5.69B | $2.25B | 39.49% |
| 2012-12-31 | $5.67B | $2.25B | 39.68% |
| 2012-09-30 | $5.63B | $2.26B | 40.17% |
| 2012-06-30 | $5.62B | $2.28B | 40.50% |
| 2012-03-31 | $5.60B | $2.28B | 40.79% |
| 2011-12-31 | $5.54B | $2.28B | 41.05% |
| 2011-09-30 | $5.47B | $2.26B | 41.22% |
| 2011-06-30 | $5.34B | $2.21B | 41.44% |
| 2011-03-31 | $5.18B | $2.16B | 41.71% |
| 2010-12-31 | $5.00B | $2.10B | 41.95% |
| 2010-09-30 | $4.87B | $2.05B | 41.96% |
| 2010-06-30 | $4.78B | $2.02B | 42.14% |
| 2010-03-31 | $4.73B | $1.99B | 42.00% |
| 2009-12-31 | $4.70B | $1.97B | 41.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $23.110B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.373B | 28.07 |
| CVS Health (CVS) | United States | $89.823B | 11.17 |
| Elevance Health (ELV) | United States | $69.805B | 9.39 |
| Cencora (COR) | United States | $58.879B | 19.61 |
| DiDi Global (DIDIY) | China | $28.380B | 30.15 |
| Natera (NTRA) | United States | $22.048B | 0.00 |
| BioMerieux (BMXMF) | France | $17.636B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.729B | 0.00 |
| ICON (ICLR) | Ireland | $14.556B | 14.01 |
| Medpace Holdings (MEDP) | United States | $13.083B | 34.63 |
| Solventum (SOLV) | United States | $12.631B | 13.03 |
| CochLear (CHEOY) | Australia | $12.527B | 0.00 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Revvity (RVTY) | United States | $10.644B | 18.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $9.863B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.237B | 0.00 |
| Avantor (AVTR) | United States | $8.781B | 12.88 |
| Charles River Laboratories (CRL) | United States | $7.854B | 14.90 |
| HealthEquity (HQY) | United States | $7.700B | 33.73 |
| Bausch + Lomb (BLCO) | Canada | $5.147B | 34.62 |
| Sotera Health (SHC) | United States | $4.630B | 25.87 |
| BrightSpring Health Services (BTSG) | United States | $4.186B | 31.93 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.455B | 79.14 |
| Surgery Partners (SGRY) | United States | $3.057B | 38.45 |
| Alignment Healthcare (ALHC) | United States | $2.974B | 0.00 |
| Concentras Parent (CON) | United States | $2.966B | 18.81 |
| Organon (OGN) | United States | $2.436B | 2.65 |
| Premier (PINC) | United States | $2.104B | 19.50 |
| Progyny (PGNY) | United States | $1.940B | 41.02 |
| Ardent Health (ARDT) | United States | $1.863B | 7.19 |
| PACS (PACS) | United States | $1.817B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.518B | 25.71 |
| Pediatrix Medical (MD) | United States | $1.417B | 9.46 |
| Teladoc Health (TDOC) | United States | $1.276B | 0.00 |
| Omada Health (OMDA) | $1.240B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.132B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.812B | 4.76 |
| AMN Healthcare Services Inc (AMN) | United States | $0.778B | 9.62 |
| CareDx (CDNA) | United States | $0.648B | 11.93 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.598B | 102.50 |
| Nutex Health (NUTX) | United States | $0.515B | 7.80 |
| Agilon Health (AGL) | United States | $0.501B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.482B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 7.01 |
| SBC Medicals (SBC) | United States | $0.413B | 9.07 |
| So-Young (SY) | China | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.411B | 27.03 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.391B | 0.00 |
| Oncology Institute (TOI) | United States | $0.334B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.157B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.116B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| KindlyMD (NAKA) | United States | $0.076B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| ModivCare (MODV) | United States | $0.027B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |